Farther Finance Advisors’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.8K | Buy |
105
+20
| +24% | +$342 | ﹤0.01% | 3730 |
|
|
2025
Q1 | $5.26K | Sell |
85
-219
| -72% | -$13.6K | ﹤0.01% | 3033 |
|
|
2024
Q4 | $37K | Buy |
304
+2
| +0.7% | +$243 | ﹤0.01% | 1805 |
|
|
2024
Q3 | $37.7K | Buy |
302
+12
| +4% | +$1.5K | ﹤0.01% | 1789 |
|
|
2024
Q2 | $45.5K | Buy |
290
+222
| +326% | +$34.8K | ﹤0.01% | 1457 |
|
|
2024
Q1 | $8.73K | Buy |
68
+3
| +5% | +$385 | ﹤0.01% | 1816 |
|
|
2023
Q4 | $6.27K | Buy |
65
+43
| +195% | +$4.15K | ﹤0.01% | 1848 |
|
|
2023
Q3 | $2.67K | Buy |
22
+3
| +16% | +$364 | ﹤0.01% | 1747 |
|
|
2023
Q2 | $2.18K | Hold |
19
| – | – | ﹤0.01% | 1723 |
|
|
2023
Q1 | $2.62K | Hold |
19
| – | – | ﹤0.01% | 1542 |
|
|
2022
Q4 | $2.46K | Buy |
+19
| New | +$2.46K | ﹤0.01% | 1383 |
|